On April 20, the Parliamentary Assembly of the Council of Europe called on member States to provide for a convention that would define a new offense relating to pharmaceutical crime. Noting that counterfeit medicines affect 10% of the world medicines market and the losses are estimated at about 500 billion euros a year, the Assembly resolved that delineating specific offenses would better enable the prosecution of counterfeiters.
For more information, see here.